12 April 2017 Partnership Agreement finalized with PENTAX Europe GmbH regarding sales and marketing of absorbable local hemostat“PuraStat®”in France, the Netherlands, and Portugal
04 April 2017 Execution of License Agreement for Hemostat in China
28 April 2016 Partnership Agreement concluded with Kaplan regarding sales and marketing of absorbable local hemostat "PuraStat®"in Chile
05 April 2016 [Delayed] Patent Granted for "Cardiac Tissue Regeneration" with Self-Assembling Peptide Technology in Japan
15 March 2016 CONSOLIDATED FINANCIAL REPORT For the Third Quarter of Fiscal Year Ending April 30, 2016
22 February 2016 Absorbable Hemostat PuraStat® Product Registration Obtained in Mexico
18 February 2016 Partnership Agreement concluded with Genelife S.A regarding sales and marketing of absorbable local hemostat "PuraStat®" in Mexico
15 February 2016 Announcement of Change of Representative Directors
10 February 2016 Revision of Forecast of Financial Results for FY2015 and Extraordinary loss
25 January 2016 Absorbable Hemostat PuraStat® Product Registration Obtained in Thailand
22 January 2016 Absorbable Hemostat PuraStat® Product Registration Obtained in Australia
05 January 2016 Patent granted on "3-D Cell Culture Scaffold" in Canada with self-assembling peptide technology exclusively licensed by MIT
28 December 2015 Partnership Agreement concluded with Transmedic Pte Ltd regarding sales and marketing of 「PuraStat®」in Singapore, Malaysia and Brunei
16 December 2015 CONSOLIDATED FINANCIAL REPORT For the Second Quarter of Fiscal Year Ending April 30, 2016
04 November 2015 Absorbable Hemostat "TDM-621"Product Registration Obtained in Brazil
05 October 2015 Partnership Agreement concluded with Maquet Australia Pty Ltd regarding sales and marketing of absorbable local hemostat 「PuraStat®」in Australia
15 September 2015 Patent Granted for "Transfection Agent (Agent for Transfer of Nucleic Acids into Cells)" Using the 3D-Matrix Peptide Technology
23 July 2015 Absorbable Hemostat "TDM-621" Product Registration Obtained in Colombia
10 July 2015 Partnership Agreement concluded with Daewoong Pharmaceutical Co., Ltd. regarding sales and marketing of absorbable local hemostat 「PuraStat®」in ASEAN
7 July 2015 Start of an Investigator-Initiated Clinical Trial for Treatment-Resistant Breast Cancer Patients with Novel siRNA Nucleic Acid Formulation “TDM-812” at the National Cancer Center
27 May 2015 Subsidiary Foundation in the Netherlands